
|Articles|October 30, 2017
- October 2017 Diabetes
- Volume 83
- Issue 10
Can You Read These Rxs? (October 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
almost 9 years ago
Case Studies (October 2017)almost 9 years ago
Pet Peeves (October 2017)almost 9 years ago
Rx Product News (October 2017)almost 9 years ago
Ingrezzaalmost 9 years ago
OTC Product News (October 2017)almost 9 years ago
Self-Care for Diabetesabout 9 years ago
Are Fad Diets Just a Fad?about 9 years ago
Does an Employee Have Access to Her PDMP Database Records?about 9 years ago
Who Is to Blame for the Opioid Crisis?about 9 years ago
Vaccine Abbreviations and Acronyms Contribute to ErrorsAdvertisement
Related to this article

A current pharmacy resident provides insights on how pharmacy students can manage the transition from student to resident.

A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.

Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.

The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.

Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.

Two recent graduates share strategies for standing out in the competitive fellowship application process.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Beyond Prescription Volume: Measuring the Pharmacist’s Value
2
Medicare GLP-1 Bridge Runs Outside Part D and Pharmacy Teams Need a Different Workflow
3
SGLT2 Inhibitors Benefit Frail Adults With T2D, Remain Underused
4
FDA Approves Talazoparib With Enzalutamide for HRR-Mutated Metastatic Prostate Cancer
5


